Program Goals
The purpose of this CME activity is to educate practicing physicians and other healthcare professionals about the clinical evidence supporting nutritional ketosis as a treatment for Type 2 diabetes. This evidence demonstrates that a ketogenic diet can effectively improve insulin resistance, glycemic control, and various metabolic parameters. By presenting the current evidence, we aim to help clinicians understand when and how to implement this dietary intervention safely and effectively.
Target Audience
This activity is designed for primary care and psychiatric physicians, cardiologists, endocrinologists, nurse practitioners and physician assistants as well as licensed mental health therapists and dieticians. All levels of experience are welcome
Learning Objectives
After completing this activity, the participant should be better able to:
1. Explain the relationship between insulin resistance and Type 2 diabetes development.
2. Describe how the ketogenic diet improves insulin sensitivity.
3. Identify the clinical markers and diagnostic criteria for insulin resistance and Type 2 diabetes.
4. Recognize the relationship between insulin resistance and cardiovascular risk.
5. Describe the evidence showing superior outcomes of ketogenic diets compared to low-fat diets for diabetes management.
6. Recognize the important clinical variables and potential risks when implementing a ketogenic diet in diabetic patients.
7. Describe appropriate diabetes medication adjustments needed when initiating a ketogenic diet.
8. Incorporate acquired knowledge on the latest findings on Ketogenic Diet as a Treatment for Type II Diabetes into current practice to better address the needs of their patients, to educate patients, and to optimize patient outcomes.
 |
Mariela Glandt, MD Endocrinologist CEO, OwnaHealth |
 |
Bret Scher, MD |
European Accreditation Council for Continuing Medical Education (EACCME)
EACCME Accreditation Statement
EACCME Accreditation is pending.
EACCME Term Offering
Pending
American Academy of Family Physicians (AAFP) Accreditation
AAFP Accreditation Statement
The AAFP has reviewed The Ketogenic Diet as a Treatment for Type ll Diabetes and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit(s).
Term of Approval is from 11/10/2025 to 11/10/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Educational Grant
This activity is supported by an educational grant from Metabolic Mind which is a non-profit organization.
